Litfulo Patient Assistance Program

(ritlecitinib)

Key Takeaways

  1. Litfulo® (ritlecitinib) is an oral prescription medication approved to treat severe alopecia areata in adults and adolescents 12 years of age and older.
  2. Litfulo is a selective JAK3 and TEC family kinase inhibitor that helps reduce the immune system's attack on hair follicles, promoting hair regrowth in many patients.
  3. Litfulo carries an FDA Boxed Warning for serious infections, cancer, major cardiovascular events, blood clots, and other serious risks associated with JAK inhibitors.
  4. Prescription Hope may help eligible individuals access manufacturer-sponsored patient assistance programs that can make Litfulo more affordable.

 

Introduction

Severe alopecia areata is an autoimmune condition that causes the immune system to attack healthy hair follicles, leading to patchy or extensive hair loss on the scalp, face, and body. The condition can affect both adults and adolescents and may have a significant emotional and psychological impact on quality of life.

Litfulo is an oral prescription medication approved to treat severe alopecia areata in adults and adolescents 12 years of age and older. By targeting specific immune signaling pathways involved in the autoimmune process, Litfulo helps reduce inflammation around hair follicles and may promote meaningful hair regrowth in eligible patients.

Prescription Hope offers qualified patients access to patient assistance programs, which provide brand-name medications at affordable rates.

What Is the Litfulo Patient Assistance Program?

Understanding Litfulo Prescription Assistance

Due to the high cost of many specialty medications, patients often search for Litfulo patient assistance programs or help paying for Litfulo.

Manufacturers are aware that due to the cost of these medications, patients need financial relief for the costs associated with Litfulo. As a result, many manufacturers offer patient assistance programs to help qualified patients offset the cost of treatment.

How Expert Advocates Help Make Litfulo More Affordable

Personalized Medication Assistance

Patients seeking trusted prescription assistance specialists need to look no further than Prescription Hope. At Prescription Hope, our patient support services take care of the entire application process for patient assistance programs, from beginning to end.

Our dedicated team manages form completion, coordination with healthcare providers and manufacturers, document and signature collection, and all the administrative tasks associated with patient assistance programs.

Ongoing Patient Support

Prescription Hope not only provides application assistance services, but we also offer long-term medication assistance. Our team handles all the minutiae of applying to these programs, including form and document updates, issue resolution, program monitoring, yearly renewals, and even refill scheduling.

Litfulo Price Comparison

vs

Prescription Hope logo

Estimated Retail Price*

$4,290.32

30-Day Supply

Prescription Hope Price

$70

Per Month, NO Matter The Retail Price

*Source: Drugs.com

Navigating Alopecia Areata Treatment Costs

Medications for Alopecia Areata can be exceedingly expensive, but Litfulo cost assistance through Prescription Hope can make all the difference.

For $70.00 per month, per medication, qualifying patients receive access to specialty Alopecia Areata medication assistance without any hidden charges or fees, variable pricing systems, or medication costs.

Litfulo Patient Assistance Eligibility

General Eligibility Requirements

While determining specific Litfulo patient assistance qualifications is best done by enrolling with Prescription Hope, it is always beneficial to understand general prescription assistance requirements.

These requirements include:

Income: Each program maintains its own income threshold.

Insurance: Each program maintains its own requirement regarding insurance coverage status.

Prescription: All qualified patients must have a valid prescription for their brand-name medication that they wish to apply for.

U.S. Residency: All qualified patients must have legal U.S. residency.

Simple Enrollment With Expert Support

Getting Started With Enrollment

Those who wish to enroll in Litfulo assistance can enroll with Prescription Hope today. Enrollment with Prescription Hope only takes 6 simple steps:

  1. Submit Information: Our online form can be completed in a few minutes.
  2. Advocate Contact: A patient advocate will contact you within 1-2 business days.
  3. Document Collection: Following a quick prequalification, our team will collect needed documents.
  4. Provider Coordination: We connect with your healthcare provider to secure vital signatures.
  5. Program Submission: Our team completes your application packet, submits it, and continues to follow up with the manufacturer.
  6. Medication Delivery: Once approved, qualified patients can typically expect to receive their medications within 2 weeks, though shipping times may vary. All medication shipments come directly from the manufacturer to your home or doctor’s office.

Understanding Litfulo

How Litfulo Works

Litfulo works by blocking Janus kinase 3 (JAK3) and TEC family kinases, proteins involved in immune system signaling.

In people with alopecia areata, the immune system mistakenly attacks healthy hair follicles. By selectively inhibiting JAK3 and TEC family kinases, Litfulo reduces immune signaling involved in the autoimmune attack on hair follicles. Although the precise mechanism by which Litfulo improves alopecia areata is not fully understood, this reduction in inflammatory signaling allows hair growth to resume in many patients.

What Conditions Does Litfulo Treat?

Litfulo is FDA-approved for the treatment of severe alopecia areata in adults and adolescents 12 years of age and older.

Alopecia areata is an autoimmune condition in which the immune system attacks hair follicles, leading to patchy or widespread hair loss on the scalp, face, and body.

Limitation of Use

Litfulo is not recommended for use in combination with:

  • Other JAK inhibitors
  • Biologic immunomodulators
  • Cyclosporine
  • Other potent immunosuppressants

Benefits of Treatment

For eligible patients with severe alopecia areata, Litfulo may:

  • Promote significant scalp hair regrowth
  • Help improve eyebrow and eyelash hair growth in some patients
  • Reduce ongoing autoimmune damage to hair follicles
  • Improve appearance and quality of life
  • Offer an FDA-approved treatment option for severe alopecia areata in adolescents 12 years of age and older
  • Provide a convenient once-daily oral treatment option

Individual responses vary, and continued treatment may be necessary to maintain hair regrowth.

Important Safety Information and Side Effects

Litfulo carries an FDA Boxed Warning.

The boxed warning highlights increased risks of:

  • Serious infections, including tuberculosis, fungal infections, and opportunistic infections
  • Increased risk of all-cause mortality observed with another JAK inhibitor in patients with rheumatoid arthritis
  • Malignancies, including lymphoma and lung cancer
  • Major adverse cardiovascular events (MACE), including heart attack, stroke, and cardiovascular death, observed with another JAK inhibitor in patients with rheumatoid arthritis.
  • Thrombosis, including deep vein thrombosis (DVT), pulmonary embolism, and arterial thrombosis

The most commonly reported side effects include:

  • Headache
  • Diarrhea
  • Acne
  • Rash
  • Hives (urticaria)
  • Fever
  • Dizziness
  • Hair follicle inflammation (folliculitis)
  • Upper respiratory tract infection
  • Nasopharyngitis
  • Herpes zoster (shingles)
  • Low red blood cell count (anemia)
  • Increased creatine phosphokinase (CPK)

Laboratory abnormalities may include:

  • Decreased lymphocyte counts
  • Decreased platelet counts
  • Elevated liver enzymes

Patients should discuss the following risks with their healthcare provider before and during treatment:

  • Serious bacterial, viral, fungal, or opportunistic infections
  • Tuberculosis screening before treatment
  • Viral reactivation, including herpes zoster
  • Changes in blood cell counts
  • Increased liver enzymes
  • Creatine phosphokinase (CPK) elevations
  • Increased risk of certain cancers
  • Cardiovascular events
  • Blood clots
  • Avoidance of live vaccines during treatment

Routine laboratory monitoring is recommended before and during treatment.

Based on animal studies, Litfulo may cause fetal harm. Females of reproductive potential should use effective contraception during treatment and for 1 month after the last dose. Patients should notify their healthcare provider immediately if pregnancy occurs during treatment.

Patients should not breastfeed during treatment and for approximately 14 hours after the final dose (approximately six elimination half-lives) because it is unknown whether ritlecitinib passes into human breast milk and because of the potential for serious adverse reactions in a breastfed child.

Litfulo may interact with:

  • Strong CYP3A inducers
  • Strong CYP1A2 inhibitors that may increase exposure to certain CYP1A2 substrate medications used concurrently
  • Other immunosuppressive medications
  • Medications that affect lymphocyte or platelet counts
  • Live vaccines

Patients should always inform their healthcare provider about all prescription medications, over-the-counter medicines, vitamins, and herbal supplements before beginning treatment.

Litfulo is taken orally as a capsule once daily and may be taken with or without food. Capsules should be swallowed whole. Treatment should be prescribed and monitored by dermatologists or other healthcare providers experienced in treating autoimmune skin disorders. Laboratory testing is recommended before starting treatment and periodically thereafter, including complete blood counts (CBC), liver function tests, tuberculosis screening, and evaluation for hepatitis B and hepatitis C when clinically appropriate.

Access to Multiple Medications

Support Beyond Litfulo

Are you looking for Alopecia Areata medication support along with other specialty medication access? At Prescription Hope, we routinely help qualifying patients access multiple medication assistance programs at once. Whether one or many, our dedicated teams provide all services for a simple $70.00 per medication, per month.

Why Choose Prescription Hope

Patient-Focused Medication Support

For two decades, Prescription Hope’s patients have trusted our patient-centered assistance and support for their prescription affordability. Join the hundreds of thousands of others who have benefited from Prescription Hope’s care and advocacy.

Simplified Access to Prescription Medications

At Prescription Hope, our Alopecia Areata medication access and prescription assistance helps to provide qualified patients the support that they need to lower their medication costs and have peace of mind regarding prescription medication prices.

Ongoing Prescription Assistance

Assistance with Alopecia Areata treatment support is not the only thing we provide at Prescription Hope; we also provide long-term medication support. Our dedicated team of patient advocates handles all the administrative work, such as form and document updates, issue resolution, program monitoring, yearly renewals, and even scheduling refills.

 

If you need access to affordable Litfulo, then be sure to enroll with Prescription Hope today!

Frequently Asked Questions

It's Easy!

Submit Enrollment Form

Getting started is free and easy! Simply complete the online enrollment form. 

Receive Welcome Call

An Enrollment Specialist will reach out to you for a personalized welcome call.

We Manage The Process

Your dedicated team manages your account month after month, allowing you to focus on what matters most—your health.

Helpful Articles

Latest News & Stories

Save Money On Your Prescriptions Today!